Psomagen Balance Sheet Health

Financial Health criteria checks 4/6

Psomagen has a total shareholder equity of ₩31.9B and total debt of ₩88.9M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are ₩44.1B and ₩12.2B respectively.

Key information

0.3%

Debt to equity ratio

₩88.95m

Debt

Interest coverage ration/a
Cash₩11.67b
Equity₩31.92b
Total liabilities₩12.20b
Total assets₩44.12b

Recent financial health updates

Recent updates

Companies Like Psomagen (KOSDAQ:950200) Are In A Position To Invest In Growth

Aug 28
Companies Like Psomagen (KOSDAQ:950200) Are In A Position To Invest In Growth

A Look At The Fair Value Of Psomagen, Inc. (KOSDAQ:950200)

Jul 05
A Look At The Fair Value Of Psomagen, Inc. (KOSDAQ:950200)

We're Not Very Worried About Psomagen's (KOSDAQ:950200) Cash Burn Rate

Jan 13
We're Not Very Worried About Psomagen's (KOSDAQ:950200) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: A950200's short term assets (₩22.7B) exceed its short term liabilities (₩8.9B).

Long Term Liabilities: A950200's short term assets (₩22.7B) exceed its long term liabilities (₩3.3B).


Debt to Equity History and Analysis

Debt Level: A950200 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A950200's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A950200 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if A950200 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies